← FDA Drug Approvals (Drugs@FDA)
NIFEDIPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMADAX · Approved 2022-11-18
Drug application
- FDA Application #
ANDA216019- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NIFEDIPINE
- Generic name
- Nifedipine
- Active ingredients
- NIFEDIPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PHARMADAX
- First approval
- 2022-11-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown